Table 1 Demographic and treatment characteristics of participants (N = 233)
Variable | N* | N (%) Mean(SD) Median (IQR) | Viral load < 20 copies/mL n = 161 | Viral load ≥ 20 copies/mL n = 72 | ||
|---|---|---|---|---|---|---|
| Â | Â | Â | N* | Mean, Median SD/IQR/% | N* | Mean, Median SD/IQR/% |
Sex | ||||||
Female | 164 | 70.4% | 117 | 71.3% | 47 | 65% |
Male | 69 | 29.6% | 44 | 63.8% | 25 | 35% |
Age |  | 42(34–50) |  | 43 (37–51) |  | 40 (27.5–49) |
Years since first positive HIV test Median (IQR) |  | 7.2 (2.6–11.9) |  | 6.8 (2.3–11.3) |  | 8.5 (4.5–12.9) |
Years on current ART Median (IQR) |  | 4.4 (2.1–8.0) |  | 4.3 (1.8–7.4) |  | 4.7 (1.3–8.1) |
ART Regimen | ||||||
NVP + AZT + 3TC | 36 | 15% | 23 | 14% | 13 | 18% |
EFV + TDF + 3TC | 74 | 32% | 60 | 37% | 14 | 20% |
EFV + TDF + FTC | 13 | 6% | 11 | 7% | 2 | 3% |
EFV + AZT + 3TC | 18 | 8% | 12 | 8% | 6 | 8% |
EFV + ATV | ||||||
EFV + ABC + 3TC | ||||||
ATV/r + AZT + 3TC | 29 | 12% | 11 | 7% | 18 | 25% |
ATV/r + TDF + FTC | ||||||
ATV/r + ABC + 3TC | ||||||
LPV/r + AZT + 3TC | 18 | 8% | 13 | 8% | 5 | 7% |
LPV/r + TDF + FTC | ||||||
LPV/r + ABC + 3TC | ||||||
DTG + 3TC + TDF | 37 | 16% | 26 | 16% | 11 | 15% |
DTG + AZT + 3TC | ||||||
DTG + ABC + 3TC | ||||||
Missing(ART) | 8 | 3% | 5 | 3% | 3 | 4% |